Jun 17, 2026 04:15PM
Jun 17, 2026 04:15PM
Jun 15, 2026 07:02AM
Jun 15, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 4, 2026 07:00AM
May 26, 2026 07:00AM Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting
May 21, 2026 07:00AM
May 12, 2026 07:00AM
May 12, 2026 07:00AM
Apr 16, 2026 07:00AM
Apr 16, 2026 07:00AM
Apr 14, 2026 07:00AM
Apr 14, 2026 07:00AM Findings From Long-Term Analysis of the Effects of LYBALVI® (olanzapine and samidorphan) on Negative Symptoms of Schizophrenia Published in The Journal of Clinical Psychiatry
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM
Mar 24, 2026 08:52AM
Feb 25, 2026 06:55AM
Feb 25, 2026 06:55AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Jan 6, 2026 07:04AM
Jan 6, 2026 07:00AM
Nov 19, 2025 06:00AM
Nov 19, 2025 06:00AM
Nov 17, 2025 05:52AM
Nov 17, 2025 05:45AM
Nov 14, 2025 05:45AM Avadel receives $23 per share takeover bid from Lundbeck
Nov 14, 2025 05:45AM
Nov 12, 2025 09:57AM
Oct 28, 2025 07:00AM
Oct 22, 2025 07:00AM
Oct 22, 2025 07:00AM
Sep 10, 2025 09:16AM
Jul 29, 2025 07:00AM Alkermes plc Reports Second Quarter 2025 Financial Results
Jun 2, 2025 07:00AM
May 1, 2025 07:00AM
Feb 12, 2025 07:00AM
Jan 29, 2025 09:12AM
Jan 6, 2025 10:35AM
Jan 2, 2025 01:02PM
Oct 24, 2024 07:00AM Alkermes plc Reports Third Quarter 2024 Financial Results
Jul 24, 2024 07:00AM
May 14, 2024 07:00AM
May 1, 2024 07:00AM
Apr 8, 2024 07:22AM
Apr 8, 2024 07:00AM
Feb 15, 2024 07:00AM
Jan 3, 2024 07:03AM Alkermes (ALKS) Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI
Jan 3, 2024 07:00AM

323,555 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All